Fischer Medical Ventures Ltd. (formerly Fischer Chemic Limited), through its subsidiary Time Medical International Ventures (India) Private Limited, has announced an exclusive global partnership with The Therapy Platform PTE. Ltd. to innovate in the mental healthcare sector using advanced technology and creative solutions.
The Therapy Platform PTE. Ltd. is a mental health tech firm dedicated to improving psychological counselling services, reducing mental healthcare costs, and alleviating socio-economic burdens. With therapists primarily in Southeast Asia, the company offers both online and offline counselling and psychotherapy services. By incorporating artificial intelligence into their services, they have developed AI products to enhance therapy outcomes and reduce overall costs.
Sarah Poh, Founder of The Therapy Platform PTE. Ltd., emphasized that a significant global population struggles with mental disorders, but only 10-12% seek help due to stigma, lack of awareness, and limited access to professional services. She explained that their AI chatbots provide discreet and affordable mental health support, connecting users who need further assistance with professionals. Poh expressed optimism about the partnership with Fischer MVL, viewing it as a major step toward making mental healthcare more accessible and effective worldwide.
Ravindran Govindan, Chairman and Managing Director of Fischer MVL, remarked that the alliance with The Therapy Platform reflects their commitment to investing in mental healthcare solutions. He described the sector as essential yet under-served and expressed a desire to lead globally in this field. Govindan highlighted that leveraging AI and advanced technology would enable them to provide comprehensive diagnostic and monitoring solutions, empowering healthcare providers and patients alike.